Aims: Titanium-nitride-oxide-coated bioactive stents (BAS) have demonstrated a favourable outcome when compared with paclitaxel-eluting stents i
1. Heart Center, Satakunta Central Hospital, Pori, Finland; 2. Department of Internal Medicine, Division of Cardiology, University of Oulu, Oulu, Finland; 3. Department of Medicine, Turku University Hospital, Turku, Finland; 4. Interven
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
bioactive stentstitaniumeverolimus-eluting stentsacute coronary syndromeoutcomemyocardial infarction
Read next articleDedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population